IL18 and metabolic dysfunction-associated steatohepatitis: (33) found that the IL-18 expression was elevated in patients with liver cirrhosis compared with healthy controls, and mice deficient for il18 exhibit reduced HF in the nonalcoholic steatohepatitis (NASH)-induced HF model.